X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cholamandalam Invest. with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CHOLAMANDALAM INVEST. vs INDOCO REMEDIES - Comparison Results

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CHOLAMANDALAM INVEST. INDOCO REMEDIES CHOLAMANDALAM INVEST./
INDOCO REMEDIES
 
P/E (TTM) x 16.6 37.2 44.8% View Chart
P/BV x 7.7 2.9 263.9% View Chart
Dividend Yield % 0.3 0.8 36.8%  

Financials

 CHOLAMANDALAM INVEST.   INDOCO REMEDIES
EQUITY SHARE DATA
    CHOLAMANDALAM INVEST.
Mar-14
INDOCO REMEDIES
Mar-17
CHOLAMANDALAM INVEST./
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs294360 81.6%   
Low Rs205249 82.3%   
Sales per share (Unadj.) Rs224.3119.0 188.5%  
Earnings per share (Unadj.) Rs25.78.4 307.5%  
Cash flow per share (Unadj.) Rs27.415.2 180.2%  
Dividends per share (Unadj.) Rs3.501.60 218.8%  
Dividend yield (eoy) %1.40.5 267.1%  
Book value per share (Unadj.) Rs159.770.7 225.9%  
Shares outstanding (eoy) m143.1992.15 155.4%   
Bonus/Rights/Conversions PI--  
Price / Sales ratio x1.12.6 43.5%   
Avg P/E ratio x9.736.4 26.6%  
P/CF ratio (eoy) x9.120.0 45.5%  
Price / Book Value ratio x1.64.3 36.3%  
Dividend payout %13.619.1 71.1%   
Avg Mkt Cap Rs m35,74028,083 127.3%   
No. of employees `0002.66.0 42.2%   
Total wages/salary Rs m1,9412,167 89.6%   
Avg. sales/employee Rs Th12,597.01,817.0 693.3%   
Avg. wages/employee Rs Th761.3359.0 212.1%   
Avg. net profit/employee Rs Th1,444.2127.7 1,131.1%   
INCOME DATA
Net Sales Rs m32,12210,968 292.9%  
Other income Rs m68140 1,715.9%   
Total revenues Rs m32,80411,007 298.0%   
Gross profit Rs m22,8041,565 1,457.5%  
Depreciation Rs m246633 38.9%   
Interest Rs m17,69462 28,492.3%   
Profit before tax Rs m5,545909 609.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,862139 1,342.5%   
Profit after tax Rs m3,683771 477.9%  
Gross profit margin %71.014.3 497.6%  
Effective tax rate %33.615.3 220.2%   
Net profit margin %11.57.0 163.2%  
BALANCE SHEET DATA
Current assets Rs m75,5725,725 1,320.1%   
Current liabilities Rs m92,8135,454 1,701.7%   
Net working cap to sales %-53.72.5 -2,174.7%  
Current ratio x0.81.0 77.6%  
Inventory Days Days062 0.0%  
Debtors Days Days272 2.6%  
Net fixed assets Rs m7435,307 14.0%   
Share capital Rs m1,433184 777.3%   
"Free" reserves Rs m18,8306,331 297.4%   
Net worth Rs m22,8686,516 351.0%   
Long term debt Rs m98,3301,323 7,431.8%   
Total assets Rs m215,44211,970 1,799.9%  
Interest coverage x1.315.6 8.4%   
Debt to equity ratio x4.30.2 2,117.5%  
Sales to assets ratio x0.10.9 16.3%   
Return on assets %9.97.0 142.6%  
Return on equity %16.111.8 136.2%  
Return on capital %19.212.4 154.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m111,141 1.0%   
Net fx Rs m-113,366 -0.3%   
CASH FLOW
From Operations Rs m-24,467886 -2,760.2%  
From Investments Rs m-832-1,706 48.8%  
From Financial Activity Rs m27,4931,316 2,089.6%  
Net Cashflow Rs m2,194497 441.9%  

Share Holding

Indian Promoters % 57.7 59.2 97.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 12.5 18.4%  
FIIs % 31.3 6.0 521.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.7 22.4 38.8%  
Shareholders   16,861 12,805 131.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CHOLAMANDALAM INVEST. With:   INDIABULLS FIN. SER.  NALWA SONS INV  CREST VENTURES  TIMKEN INDIA  RELIGARE ENT.  



Today's Market

Sensex Trades Weak; FMCG Stocks Drag(12:30 pm)

Stock markets in India are trading in negative territory weighed by fast-moving consumer goods (FMCG) stocks.

Related Views on News

CHOLAMANDALAM INVEST. Announces Quarterly Results (4QFY18); Net Profit Up 31.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, CHOLAMANDALAM INVEST. has posted a net profit of Rs 3 bn (up 31.0% YoY). Sales on the other hand came in at Rs 15 bn (up 25.7% YoY). Read on for a complete analysis of CHOLAMANDALAM INVEST.'s quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CHOLAMANDALAM INVEST. SHARE PRICE


Sep 26, 2018 02:13 PM

TRACK CHOLAMANDALAM INVEST.

  • Track your investment in CHOLAMANDALAM INVEST. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CHOLAMANDALAM INVEST.

CHOLAMANDALAM INVEST. - TVS SRICHAKRA COMPARISON

COMPARE CHOLAMANDALAM INVEST. WITH

MARKET STATS